Search liu.se

A world-leading researcher in structural biology has been named the 2015 Tage Erlander Visiting Professor, with a placement at Linköping University.

As the corona pandemic swept across the world, virologists and protein chemists rapidly joined forces and started to collaborate. Together they were able to develop ways to test the immune response after infection, and help the healthcare system.

The European Union has awarded a 5 M€ infrastructure grant to the MOSBRI project. ProLinC, LiUs core facility for protein research, is a major part of it.

How can we understand a protein when it is never still, but constantly changes shape? This is one of the challenges for LiU researchers who are studying the cancer-related protein MYC.

Researchers in biomedicine and biotechnology have now completely new opportunities for access to specialised equipment at some of the best facilities. LiU is one of the 13 nodes in MOSBRI, a European research infrastructure for molecular biophysics.

LiU scientists are working intensely to develop two different analysis methods for the immune response that follows infection by the SARS-CoV-2 virus. One of the tests is now being used by the medical care services in Region Östergötland.

Scientists have for the first time seen how the MYC protein, which plays a central role in cancer, binds to a key protein and controls important functions in cells. The new discovery may in the long term help in the development of new cancer drugs.

Several projects at Linköping University are to receive grants for the development of research infrastructure. The total amount is of the order of a hundred million Swedish crowns, and decades of work are now bearing fruit.